Adjunct Faculty
Adjunct faculty typically have an academic or research appointment at another institution and contribute or collaborate with one or more School of Medicine faculty members or programs.
Adjunct rank detailsGaurang Daftary, MBA, MD
Associate Professor Adjunct of Obstetrics, Gynecology & Reproductive SciencesAbout
Copy Link
Titles
Associate Professor Adjunct of Obstetrics, Gynecology & Reproductive Sciences
Departments & Organizations
- All Institutions
Education & Training
- MBA
- University of Minnesota - Carlson School of Management (2017)
- MD
- Yale School of Medicine (2003)
Research
Copy Link
Research at a Glance
Publications Timeline
A big-picture view of Gaurang Daftary's research output by year.
6Publications
2Citations
Publications
2026
Enhancing ART success in overweight and obese women: Current strategies and novel evidence-based approaches
Daftary G, Daftary G, Patil S, Mishra A, Patil N. Enhancing ART success in overweight and obese women: Current strategies and novel evidence-based approaches. Journal Of IVF-Worldwide 2026, 4 DOI: 10.46989/001c.158185.Peer-Reviewed Original ResearchConceptsAssisted Reproductive Technology OutcomesLive birth rateAssisted Reproductive TechnologyAssisted reproductive technology successObese womenAdjunctive therapyPredictor of ART outcomeImpact of weight loss interventionsBirth rateDegree of weight lossPersonalized treatment protocolsRisk of miscarriageWeight lossPubMed literature searchWeight loss interventionComprehensive PubMed literature searchLetrozole-based protocolGonadotropin consumptionPaternal obesityUnderweight womenGonadotropin dosageBariatric surgeryInflammatory markersStimulated cyclesMicronutrient supplementation
2025
Impact of gonadotropin selection on risk of ovarian hyperstimulation syndrome in predicted high responders: a Menopur in Gonadotropin-releasing hormone Antagonist Single Embryo Transfer–High Responder trial analysis
Foulk R, Slater C, Karande V, Kelly L, Foster E, Heiser P, Daftary G, Lalwani S, Group M, Barmat L, Beltsos A, Boostanfar R, Crain J, DeVane G, Doody K, Doyle J, Feinberg R, Forman E, Foulk R, Frattarelli J, Jacobs M, Karande V, Klein N, Marrs R, Miller C, Orris J, Pang S, Park J, Perloe M, Schnell V, Schnorr J, Shapiro B, Slater C, Thornton K, Witz C, Yeko T, Zbella E, Arredondo F, Sharara F, Schoolcraft W. Impact of gonadotropin selection on risk of ovarian hyperstimulation syndrome in predicted high responders: a Menopur in Gonadotropin-releasing hormone Antagonist Single Embryo Transfer–High Responder trial analysis. F&S Reports 2025, 6: 251-260. PMID: 41054720, PMCID: PMC12496443, DOI: 10.1016/j.xfre.2025.07.003.Peer-Reviewed Original ResearchCitationsConceptsEarly OHSSOvarian hyperstimulation syndromeRisk of ovarian hyperstimulation syndromeOvarian hyperstimulation syndrome rateRecombinant follicle-stimulating hormoneAnti-Mullerian hormoneBaseline anti-Mullerian hormoneHP-hMGControlled ovarian stimulationOocyte yieldHyperstimulation syndromeOvarian stimulationIncidence of ovarian hyperstimulation syndromeGonadotropin-releasing hormone agonist triggerShorter duration of infertilityOvarian hyperstimulation syndrome incidenceHuman chorionic gonadotropin triggerUS fertility centersDuration of infertilitySerum anti-Mullerian hormoneHigher oocyte yieldHigh-responder patientsTreatment groupsHP-hMG stimulationHuman menopausal gonadotropin
2024
IMPACT OF GONADOTROPIN SELECTION ON RISK OF OVARIAN HYPERSTIMULATION SYNDROME (OHSS) IN PREDICTED HIGH RESPONDERS UNDERGOING OVARIAN STIMULATION: A MEGASET HR TRIAL ANALYSIS
Foulk R, Slater C, Karande V, Kelly L, Foster E, Lalwani S, Daftary G, Heiser P. IMPACT OF GONADOTROPIN SELECTION ON RISK OF OVARIAN HYPERSTIMULATION SYNDROME (OHSS) IN PREDICTED HIGH RESPONDERS UNDERGOING OVARIAN STIMULATION: A MEGASET HR TRIAL ANALYSIS. Fertility And Sterility 2024, 122: e64-e65. DOI: 10.1016/j.fertnstert.2024.07.247.Peer-Reviewed Original ResearchRandomized, Assessor-Blinded Trial Comparing Highly Purified Human Menotropin and Recombinant Follicle-Stimulating Hormone in High Responders Undergoing Intracytoplasmic Sperm Injection
Witz C, Daftary G, Doody K, Park J, Seifu Y, Yankov V, Heiser P, Group O. Randomized, Assessor-Blinded Trial Comparing Highly Purified Human Menotropin and Recombinant Follicle-Stimulating Hormone in High Responders Undergoing Intracytoplasmic Sperm Injection. Obstetrical & Gynecological Survey 2024, 79: 276-277. DOI: 10.1097/ogx.0000000000001281.Peer-Reviewed Original Research
2023
Reply of the Authors: Randomized, assessor-blinded trial comparing highly purified human menotropin and recombinant follicle-stimulating hormone in high responders undergoing intracytoplasmic sperm injection
Witz C, Doody K, Park J, Daftary G, Heiser P. Reply of the Authors: Randomized, assessor-blinded trial comparing highly purified human menotropin and recombinant follicle-stimulating hormone in high responders undergoing intracytoplasmic sperm injection. Fertility And Sterility 2023, 121: 359. PMID: 37995797, DOI: 10.1016/j.fertnstert.2023.11.015.Peer-Reviewed Original ResearchCorrigendum to “Host immunity and KLF 11 deficiency together promote fibrosis in a mouse model of endometriosis” [BBA - Mol. Basis of Dis. 1869 (2023) 166784]
Grande J, Jones T, Sun Z, Chanana P, Jaiswal I, Leontovich A, Carapanceanu N, Carapanceanu V, Saadalla A, Osman A, Famuyide A, Daftary G, Khan Z, Khazaie K. Corrigendum to “Host immunity and KLF 11 deficiency together promote fibrosis in a mouse model of endometriosis” [BBA - Mol. Basis of Dis. 1869 (2023) 166784]. Biochimica Et Biophysica Acta (BBA) - Molecular Basis Of Disease 2023, 1870: 166923. PMID: 37949756, DOI: 10.1016/j.bbadis.2023.166923.Peer-Reviewed Original ResearchCitations
Academic Achievements & Community Involvement
Copy Link
Get In Touch
Copy Link